Related Experiment Video
Updated: Jan 21, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Sophie Mavrogeni1, Loukia Koutsogeorgopoulou2, Theodoros Dimitroulas3
1Onassis Cardiac Surgery Center, Athens, Greece.
Insights
Combined brain and heart MRI may aid in assessing cardiovascular disease (CVD) and neuropsychiatric lupus erythematosus (NPSLE) risk. This approach could benefit high-risk SLE patients, particularly those with antiphospholipid syndrome, for early detection and management.
Area of Science:
- Rheumatology
- Cardiology
- Neurology
- Radiology
Background:
- Cardiovascular Disease (CVD) and Neuropsychiatric SLE (NPSLE) affect 50% and 40% of SLE patients, respectively, and are leading causes of mortality.
- Pathophysiology of NPSLE involves microangiopathy, infarcts, and atherosclerosis; brain MRI detects lesions in 50% of cases, with advanced techniques identifying pre-clinical changes.
- Cardiac involvement in SLE includes myo-pericarditis, valvular disease, heart failure, coronary disease, vasculitis, and pulmonary hypertension, detectable by classic and advanced Cardiac MRI (CMR) indices.
Purpose of the Study:
- To propose a combined brain/heart Magnetic Resonance Imaging (MRI) approach for risk stratification in Systemic Lupus Erythematosus (SLE).
- To explore the potential utility of advanced MRI techniques for early detection of pre-clinical cardiovascular and neurological damage in SLE patients.
Main Methods:
- Review of current literature on cardiovascular and neuropsychiatric manifestations of SLE.
- Discussion of the role of classic and advanced brain MRI and Cardiac MRI (CMR) in diagnosing and monitoring SLE-related complications.
- Exploration of the potential application of combined brain/heart MRI for risk stratification in specific SLE patient subgroups.
Main Results:
- Classic brain MRI shows lesions in 50% of NPSLE cases; advanced MRI can detect pre-clinical lesions in most NPSLE patients.
- Classic and advanced CMR indices enable functional and tissue characterization for early diagnosis and follow-up of CVD in SLE.
- While no clinical data currently support combined MRI in asymptomatic SLE, it shows promise for high-risk patients.
Conclusions:
- Combined brain/heart MRI may be valuable for SLE risk stratification, particularly in patients with clinical suspicion of brain/heart involvement or those at high risk for CVD/stroke, such as SLE/APS.
- This approach could also benefit SLE patients with multi-organ involvement, concurrent cardiac and neurological issues, or recent onset of arrhythmia/heart failure.
- Further clinical data are needed to establish the definitive role of combined brain/heart MRI in SLE management.
Abstract:
Cardiovascular Disease (CVD) in Systemic Lupus Erythematosus (SLE) and Neuropsychiatric SLE (NPSLE) has an estimated prevalence of 50% and 40%, respectively and both constitute major causes of death among SLE patients. In this review, a combined brain/heart Magnetic Resonance Imaging (MRI) for SLE risk stratification has been proposed. The pathophysiologic background of NPSLE includes microangiopathy, macroscopic infarcts and accelerated atherosclerosis. Classic brain MRI findings demonstrate lesions suggestive of NPSLE in 50% of the NPSLE cases, while advanced MRI indices can detect pre-clinical lesions in the majority of them, but their clinical impact still remains unknown. Cardiac involvement in SLE includes myo-pericarditis, valvular disease/endocarditis, Heart Failure (HF), coronary macro-microvascular disease, vasculitis and pulmonary hypertension. Classic and advanced Cardiovascular Magnetic Resonance (CMR) indices allow function and tissue characterization for early diagnosis and treatment follow-up of CVD in SLE. Although currently, there are no clinical data supporting the combined use of brain/heart MRI in asymptomatic SLE, it may have a place in cases with clinical suspicion of brain/heart involvement, especially in patients at high risk for CVD/stroke such as SLE with antiphospholipid syndrome (SLE/APS), in whom concurrent cardiac and brain lesions have been identified. Furthermore, it may be of value in SLE with multi-organ involvement, NPSLE with concurrent cardiac involvement, and recent onset of arrhythmia and/or heart failure.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Atomic Nuclei: Magnetic Resonance
Nuclear Magnetic Resonance (NMR): Overview
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Functional Brain Systems: Limbic System
Resonance

